Clinical Trial Update: Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated whether a single dose of Cervarix in girls could prevent HPV infection as effectively as the standard three-dose Gardasil regimen i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)
• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papillomavirus-Related Cervical Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2025-07-20